AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $5.16
- 52-wk high
- $5.45
- High
- $5.23
- 52-wk low
- $3.50
- Low
- $5.13
- Prev close
- $5.18
- Mkt cap
- $1.03B
- P/E
- 6.6x
- Volume
- 5.51M
- Fwd P/E
- 10.3x
- Beta
- 0.62
- P/S
- 5.7x
- P/B
- 3.9x
- Profit margin
- +84.2%
- Op margin
- -567.0%
- ROE
- +89.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
-$0.03+$0.00
-$0.03 expected
What the street expects next
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $529.0K | $1.1M | $179.1M | $1.0M |
| Cost of what it sold | $11.0K | $11.0K | $11.0K | — |
| Gross profit | $518.0K | $1.0M | $179.1M | $1.0M |
| What it spent | ||||
| Research and development | $5.8M | $5.0M | $4.1M | $2.9M |
| Sales and admin | $3.0M | $3.7M | $5.9M | $3.9M |
| Other operating costs | — | — | — | $213.0K |
| Total operating expenses | $8.8M | $8.7M | $10.0M | $7.0M |
| What was left | ||||
| Operating profit | -$8.3M | -$7.6M | $169.1M | -$6.0M |
| Interest on debt | $23.0K | $18.0K | $17.0K | $18.0K |
| Profit before tax | -$7.7M | -$3.8M | $169.7M | -$5.1M |
| Net profit | -$7.7M | -$3.8M | $169.7M | -$5.1M |
| EBITDA | -$7.7M | -$3.7M | $169.7M | -$5.1M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
60balanced
20D volatility
40%annualized
52-week range
$3.50$5.45
20D support
$4.42recent floor
20D resistance
$5.45recent ceiling
Returns
5D +1.6%20D +10.7%60D +21.4%
Price vs moving averages
SMA20 +3.3%SMA50 +8.3%SMA200 +14.9%
Volume pace
3.55xvs prior 20D
News
What the news says
1 article · 7 days
Coverage is bullish
Tone of tracked coverage
Arbutus Biopharma Launches Modified Dutch Auction Tender Offer to Repurchase Up to US$230 Million of Common Shares
Leans bullishAug 24